Cyient Limited’s stock prices jumped nearly 7 percent today and the current price stands to be Rs 1,167. The scrip touched its 52-week high mark at a price of Rs 1,193.70. In the last 5 trading sessions, the stock has gained about 10 percent ranging from Rs 1,064 to the current price levels.
Such movements in the stock prices are observed after the company announced its Q4 and annual results. Details of the same have been discussed in the write-up later on. Compay’s Board recommended a final dividend of Rs 16 per share on a face value of Rs 5 each.
Cyient Limited provides a variety of information technology (IT) and engineering services. Industries served by the company include communications, transportation, semiconductor, defense, etc. A majority of the company’s revenue is generated from the American markets.
Digging into the financials of the company, the operating revenues, as well as net profits, have improved in the recent quarters with revenues increasing from Rs 1,618 crores in Q3 to Rs 1,751 crores in Q4. The net profit numbers, during the same period, went up from Rs 156 crores in Q3 to Rs 163 crores.
Having a yearly comparison of the above-mentioned parameters, the revenues showed movement from Rs 4,534 crores in FY21-22 to Rs 6,016 crores during FY22-23 showing a 33 percent increase. On a contrasting note, the net profits slightly dipped from Rs 522 crores in FY21-22 to Rs 514 crores in FY22-23.
The profitability metrics of the company have also seen decent growth in the basic indicators of operations such as the ROE and ROCE. The ROE numbers rose from 13.25 percent in FY20-21 to 17.31 percent during FY21-22. Likewise, the ROCE ratio saw movement from 16.65 percent in FY20-21 to 21.96 percent in FY21-22.
As of the December quarter, promoters of the company hold a 23.36 percent stake. Recently, there has been a pledge of shares of 1.3 percent in the past 4 quarters. FIIs have increased their stake from 31.07 percent in Q3 to 32.61 percent in Q4.
Written by Amit Madnani
Disclaimer
The views and investment tips expressed by investment experts/broking houses/rating agencies on tradebrains.in are their own, and not that of the website or its management. Investing in equities poses a risk of financial losses. Investors must therefore exercise due caution while investing or trading in stocks. Dailyraven Technologies or the author are not liable for any losses caused as a result of the decision based on this article. Please consult your investment advisor before investing.
